Advertisement

Topics

Companies Related to "Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis" [Most Relevant Company Matches] RSS

22:44 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Efficacy Natalizumab Treatment Multiple Sclerosis" Companies 1–25 of 5,500+

Extremely Relevant

Familia Unida

Familia Unida living with Multiple Sclerosis (FULWMS) is the first bilingual, English/Spanish Multiple Sclerosis non-profit organization. It serves over thousands of individuals and families affected by Multiple Sclerosis (MS) and other disabilities.


Relevant

Premier Biomedical, Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier has licensed t...

Acorda Therapeutics, Inc.

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis, spinal cord injury and other nervous system disorders. The Company's marketed products include AMPYRA®(dalfampridine) Extended Release Tablets, 10 mg, a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS); this w...


National Multiple Sclerosis Society: Lone Star

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances ...

Jack S. Burks, MD

Jack Burks, MD is a neurologist, researcher, author, and one of the foremost authorities in Multiple Sclerosis who lectures and consults internationally on Multiple Sclerosis research and patient care issues related to Multiple Sclerosis. He holds numerous positions including:) Board Certified Neurologist (American Board of Neurology and Psychiatry) ) Certified in Neurological Rehabilitation (Amer...

Premier Biomedical Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, in collaboration with the University of Texas at El Paso and US Department of Defense, specifically targeting the treatment of Alzheimer's disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (...

Eva & Estela Wear Ur Love

Eva & Estela Wear Ur Love is a growing, family-owned t-shirt and apparel business created to raise awareness for multiple sclerosis. Eva & Estela Wear Ur Love is the entrepreneurial endeavor of Kristen Sitarski-Munoz of Williamstown, NJ. Sitarski-Munoz and her husband Ryan faced the simultaneous struggle of job losses and Ryan’s diagnosis of multiple ...

Androclus Therapeutics

Androclus Therapeutics is a clinical-stage biotechnology company developing first-in-class selective therapeutics for the treatment of autoimmune diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS) and inflammatory bowel disease (IBD), based on a proprietary epitope-specific immunotherapy technology platform. The breakthrough technology platform has a potential of producing the ...

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

Chromos

Chromos is a biopharmaceutical company with two drug development programs focused on inflammatory diseases and thrombotic disorders. BUSINESS FOCUS Developing biological therapies for the treatment of multiple sclerosis (MS), thrombotic disorders and other inflammatory diseases . PROPRIETARY PRODUCTS Two humanized monoclonal antibodies with novel mechanisms of action. CHR-1103 is being developed i...

Phase 2 Discovery, Inc.

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).At P2D, we are using our understanding of the treatme...

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

Elan Corporation, plc

Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and realizing the potential of its scientific discoveries to benefit patients and shareholders. The company has two business units: BioNeurology, focused on Alzheimer’s and Parkinson...

Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focused on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine as well as T cells for the treatment of autoimmune ...

Allon Therapeutics Inc

Allon Therapeutics Inc. (TSX:NPC) is a Canadian biotechnology company developing drugs that protect against neurodegenerative conditions such as Alzheimer’s disease, mild cognitive impairment, traumatic brain injury, stroke, multiple sclerosis and neuropathy. Allon’s drug discovery platform has resulted in the development of a unique class of peptide compounds that has demonstrated broad effic...

Apitope

Apitope International NV, based in Belgium and the UK, is a world-class drug developer of immunotherapies for the treatment of autoimmune and allergic diseases, including multiple sclerosis, factor VIII intolerance, uveitis and Graves’ disease. The Company has a patented discovery platform which enables selection of disease-modifying peptide therapies...

Consortium of Multiple Sclerosis Centers

Multiple Sclerosis Association of America

International Multiple Sclerosis Management Practice

Vascular Biogenics Ltd.

Vascular Biogenics Ltd. (VBL) is a biopharmaceutical company focused on developing novel treatments for pathologies in which vascular biology plays a critical role. Based on its leading research expertise in vascular biology VBL has developed lead candidates in the fields of cardiovascular health and solid tumor cancer treatment.Cardiovascular Health: Attacking Atherosclerosis through Anti-Inflamm...

Accelerated Cure Project

Accelerated Cure Project for Multiple Sclerosis, www.acceleratedcure.org, is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its causes. Accelerated Cure Project believes this effort can be accelerated by organizing the research process and encouraging collaboration between research organizations and clinicians....

AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals is a privately held pharmaceutical company dedicated to the development and commercialization of new therapies for the treatment of pain and other conditions where there is an unmet need for improved safety and efficacy. The company applies its proprietary dosage form and delivery technologies to enhance the safety, therapeutic benefit and commercial attractiveness of curren...

Nanna Therapeutics

Nanna Therapeutics has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advanced machine learning, TIME utilises its paradigm shift in the speed, efficiency and quality of drug discovery, as well as dramatically enhanced safety profiling, to improve clinical success. In addition to working wi...

izun Pharmaceuticals

Izun Pharmaceuticals Ltd. is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments. The Company's core technology utilizes naturally derived pharmaceutical actives for the treatment of oral disease with inflammatory components. The novel therapies co...

Pepgen Corporation

Pepgen Corporation, founded in 1992 by Dr. CP Liu is based in Alameda, CA. Pepgen is a privately held biopharmaceutical company seeking to develop and commercialize novel products for the prevention and treatment of autoimmune and viral disorders. The company's lead inflammatory product, Tauferon™, is in Phase II human clinical studies in multiple sclerosis (MS). Tauferon™ can be administered ...


More From BioPortfolio on "Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks